CClinicalTrials.gg
CompletedNCT03999060Updated Oct 8, 2019

Trigeminal Brainstem Mapping

An interventional study of Electric Current Stimulation in Headache Disorders, Primary and Migraine, sponsored by Universitätsklinikum Hamburg-Eppendorf. Completed at 1 site in Germany. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-08.

Sponsored by Universitätsklinikum Hamburg-Eppendorf · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

To what extent the somatotopy of the 3 branches of the trigeminal nerve (V1,V2,V3) as well as the greater occipital nerve (GON) in the brainstem but also in the thalamus and the insula can be mapped using functional imaging and BOLD in humans is not known but might play an important role in imaging headache diseases. The aim is to map their somatotopy by random stimulation of V1, V2, V3 and the GON with painful electrical input during acquisition of BOLD-fMRI.

02

Conditions studied

  • Headache Disorders, Primary
  • Migraine
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • healthy
  • suitable fo MRI

Exclusion criteria

Exclusion Criteria:

  • headache disease
  • psychological disorder
  • pregnancy
  • all exclusion criteria necessary for imaging in a 3 T MRI scanner
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Electric Stimulation

    Device: Electric Current Stimulation

Interventions

  • DeviceElectric Current Stimulation

    Electric stimulation with a Digitimer DS7AH HV Current Stimulator delivered with 4 shielded electrodes mounted on the participants head

05

What researchers measure

Primary outcomes

  1. Statistical Parametric Map calculated from the fMRI data on brainstem level

    At a statistical threshold of T-value 3 we will observe a somatotopical arrangement in the brainstem below the pons: Expected location for V1: within radius of 10 mm around the MNI coordinates (-1,-48,-75); Expected location for V2: within radius of 10 mm around the MNI coordinates (-4,-47,-69) Expected location for V3: within radius of 10 mm around the MNI coordinates (-1,-46,-66) Expected location for GON: within radius of 10 mm around the MNI coordinates (-1,-45,-64)

    Time frame: through study completion, an average of 9 months

  2. Statistical Parametric Map calculated from the fMRI data in the thalamus

    At a statistical threshold of T-value 4 we will observe a somatotopical arrangement in the thalamus: Expected location for V1: within radius of 10 mm around the MNI coordinates (11,-5,6); Expected location for V2: within radius of 10 mm around the MNI coordinates (13,-11,5) Expected location for V3: within radius of 10 mm around the MNI coordinates (12,-10,5) Expected location for GON: within radius of 10 mm around the MNI coordinates (15,-12,-7)

    Time frame: through study completion, an average of 9 months

  3. Statistical Parametric Map calculated from the fMRI data in the insula

    At a statistical threshold of T-value 4 we will observe a somatotopical arrangement in the insula: Expected location for V1: within radius of 10 mm around the MNI coordinates (38,-15,8); Expected location for V2: within radius of 10 mm around the MNI coordinates (37,-8,-5) Expected location for V3: within radius of 10 mm around the MNI coordinates (39,2,-11) Expected location for GON: within radius of 10 mm around the MNI coordinates (38,-12,-3)

    Time frame: through study completion, an average of 9 months

Secondary outcomes

  1. Statistical Parametric Map calculated from the fMRI data in the cerebellum

    Time frame: through study completion, an average of 9 months

  2. Statistical Parametric Map calculated from the fMRI data in the periaqueductal gray (PAG)

    Time frame: through study completion, an average of 9 months

06

Study locations

1 site
  • UKE
    Hamburg, 20246, Germany
07

References and documents

Individual participant data

Plan to share: No — Group results will be presented at international conferences as well as published in international peer-reviewed journals

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03999060
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Responsible party
Sponsor
First posted
Jun 26, 2019
Start date
Jun 28, 2019
Primary completion
Sep 27, 2019
Completion
Sep 27, 2019
Last update
Oct 8, 2019

Study contacts

Arne May, Prof. Dr.
principal investigator · Universitätsklinikum Hamburg-Eppendorf

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion